Legiant
The computed 12-month bankruptcy probability of Legiant is 0.3% (very low). The 2024 annual accounts show equity of €434k and a net result of €422k. Its solvency ranks better than 82% of 479 sector peers (fiscal year 2024). The company has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €434k |
| Net result | €422k |
| Better than sector | 82% |
| Active | 2 yrs |
Strong profile, led by profitability.
Computed on 4 of 5 axes. Not measured: growth. An unmeasured axis is not a zero: no data was read for it.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit from Kantoor S.
See plans →| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 68.9% | 22.1% | |
| Net result | €422k | €101k | |
| Equity | €434k | €165k | |
| Gross operating margin | €608k | €462k | |
| Total assets | €630k | €1.12M |
| Fiscal year | 2024 |
|---|---|
| Deposit | verkort |
| Revenue | - |
| EBITDA | €607k |
| Net profit | €422k |
| Cash flow | €425k |
| Staff costs | - |
| Income taxes | €191k |
| Dividends | - |
| Total assets | €630k |
| Equity | €434k |
| Debt | €196k |
| of which ≤ 1y | €194k |
| of which > 1y | - |
| Working capital | €436k |
| Employees (FTE) | - |
| 2024 | |
|---|---|
| Current ratio | 3.24 |
| Quick ratio | 3.24 |
| Working capital ratio | 69.1% |
| Solvency | 68.9% |
| Debt / equity | 0.45 |
| Long-term debt ratio | - |
| Interest coverage | 2291.73 |
| Gross margin | - |
| Net margin | - |
| ROA | 67.1% |
| ROE | 97.3% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €630k |
| Current assets | 29/58 | €630k |
| Amounts receivable within one year | 40/41 | €57k |
| Cash & bank | 54/58 | €571k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €630k |
| Equity | 10/15 | €434k |
| Contributions / capital | 10/11 | €12k |
| Reserves | 13 | €422k |
| Amounts payable | 17/49 | €196k |
| Amounts payable within one year | 42/48 | €194k |
| Trade debts payable within one year | 44 | €6k |
| Income statement | ||
| Gross operating margin | 9900 | €608k |
| Operating result | 9901 | €605k |
| Financial income | 75 | €9k |
| Financial charges | 65 | €265 |
| Result before taxes | 9903 | €613k |
| Income taxes | 67/77 | €191k |
| Net result for the period | 9904 | €422k |
| Result to be appropriated | 9905 | €422k |
| NACE primary | Activiteiten van advocaten(69101) |
| Legal form | Private limited company(610) |
| Incorporation | 14-12-2023 |
| Status | Active |
| Postal code | 2020 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 11809I2139/00Z004 | Flanders | 337 m² | 1 · 146 m² | 13.7 m · 4 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
22-01-2025 Registered office moved within Antwerpen
- Scheldestraat 9, 2000 Antwerpen → Jan Van Rijswijcklaan 232, 2020 Antwerpen
Technical details
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "siege_social",
"new_address": {
"raw": "Jan Van Rijswijcklaan 232, 2020 Antwerpen",
"city": "Antwerpen",
"region": "vlaams_gewest",
"street": "Jan Van Rijswijcklaan",
"country": "BE",
"postcode": "2020",
"box_number": null,
"street_number": "232",
"locality_suffix": null
},
"old_address": {
"raw": "Scheldestraat 9, 2000 Antwerpen",
"city": "Antwerpen",
"region": "vlaams_gewest",
"street": "Scheldestraat",
"country": "BE",
"postcode": "2000",
"box_number": null,
"street_number": "9",
"locality_suffix": null
},
"effective_date": "2025-01-01",
"evidence_quote": "",
"region_changed": false,
"is_statute_change": true,
"nationality_change": false,
"old_address_source": "header_volledig_adres",
"statute_clause_text": null,
"statute_article_number": null,
"effective_date_qualifier": "absolute",
"statutaire_vs_werkelijke": null,
"linguistic_region_changed": false,
"court_jurisdiction_changed": false,
"effective_date_is_approximate": false
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": "Antwerpen",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": null,
"filing_date": "2025-01-10",
"act_kind_objet": "Onderwerp akte:"
},
"decision": {
"body": "bijzondere_algemene_vergadering",
"date": "2024-12-31",
"unanimous": true
},
"subject_company": {
"kbo": "1003.368.196",
"name_full": "vosat. Legiant",
"legal_form": "BV"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Tom Van Achter",
"org_rep_person_name": null,
"person_role_at_subject": "Bestuurder"
},
"co_filed_documents": [
"Lurk B"
]
}22-11-2024 Capital increase of €1,602.17 to €11,602.17
- €10.000 → €11.602,17
- Inbreng in natura · Apport en nature
Technical details
{
"events": [
{
"kind": "agio_incorporation",
"after_eur": 11602.17,
"delta_eur": 1602.17,
"before_eur": 10000.0,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": 160,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": 10.01
},
"decrease_purpose": null,
"contribution_type": "natura",
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "Frederik Vlaminck",
"firm_city": null,
"firm_name": null,
"office_city": "Antwerpen",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2024-11-22",
"filing_date": "2024-11-20",
"act_kind_objet": "Onderwerp akte:"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2024-11-12",
"unanimous": null,
"under_authorized_capital": true,
"underlying_resolution_date": "2023-12-29"
},
"bedrijfsrevisor": {
"waived": false,
"firm_kbo": "0700.543.502",
"firm_name": "Gilles Dani\u00EBls",
"ibr_number": null,
"mission_type": "quasi_apport",
"individual_name": "Gilles DANIELS"
},
"subject_company": {
"kbo": "1003.368.196",
"name_full": "Legiant",
"legal_form": "B.V.",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"expedition",
"plan financier",
"bankattest",
"verslag bedrijfsrevisor"
],
"shareholders_after": [],
"share_classes_after": []
}21-02-2024 Capital increase of €1,602.17 to €11,602.17
- €10.000 → €11.602,17
- Inbreng in natura · Apport en nature
Technical details
{
"events": [
{
"kind": "eenhoofdigheid_declaration",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "capital_increase",
"after_eur": 11602.17,
"delta_eur": 1602.17,
"before_eur": 10000.0,
"subscribers": [
{
"kbo": "0437.350.531",
"rrn": null,
"kind": "org",
"name": "elegis - Huybrechts, Engels, Craen \u0026 Vennoten",
"share_class": null,
"liberation_pct": 100.0,
"contribution_kind": "natura",
"n_shares_subscribed": 160,
"contribution_amount_eur": 1602.17
}
],
"share_emission": {
"agio_eur": null,
"share_form": "no_nominal_value",
"share_class": null,
"n_new_shares": 160,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": "natura",
"paid_up_delta_eur": 1602.17,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "statutory_reserve_release",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": "reserves_incorporation",
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": "convert_to_apports_non_appeles"
}
],
"notary": {
"name": "Johan Kiebooms",
"firm_city": null,
"firm_name": null,
"office_city": "Antwerpen",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2024-02-21",
"filing_date": "2024-02-19",
"act_kind_objet": "Onderwerp akte:"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2023-12-29",
"unanimous": null,
"under_authorized_capital": true,
"underlying_resolution_date": null
},
"bedrijfsrevisor": {
"waived": false,
"firm_kbo": "0700.543.502",
"firm_name": "Gilles Dani\u00EBls",
"ibr_number": null,
"mission_type": "quasi_apport",
"individual_name": "Gilles DANIELS"
},
"subject_company": {
"kbo": "1003.368.196",
"name_full": "Legiant",
"legal_form": "B.V.",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"expedition",
"plan financier",
"bankattest",
"verslag bedrijfsrevisor"
],
"shareholders_after": [],
"share_classes_after": []
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameNL | Legiant |